Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 11, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 23
- +1 vs. Q4 2022
- Portfolio value
- $307.4M
- −$36.3M (−10.6%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,629,173 | $78.6M | 25.6% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $56.3M | 18.3% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $34.3M | 11.2% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $32.6M | 10.6% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $20.9M | 6.8% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $19.3M | 6.3% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $13.8M | 4.5% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $10.2M | 3.3% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $10.1M | 3.3% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $7.27M | 2.4% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $6.29M | 2.0% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $5.78M | 1.9% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $4.20M | 1.4% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $3.92M | 1.3% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 317,704 | $1.83M | 0.6% | +121,476+61.9% | Added | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $716.7K | 0.2% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $650.7K | 0.2% | 00.0% | Unchanged | History |
| APLMApollomics Inc. | CL A SHS | 13,252 | $320.7K | 0.1% | +13,252 | New | History |
| CLSDClearside Biomedical, Inc. | COM | 169,629 | $176.4K | 0.1% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $158.8K | 0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $38.8K | <0.1% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 190,494 | $23.8K | <0.1% | +190,494 | New | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $13.9K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2022 (1)
Positions held at the end of Q4 2022 that are gone from this filing.